Is RGEN a good stock to buy? We came across a bullish thesis on Repligen Corporation on R. Dennis’s Substack by OppCost. In this article, we will summarize the bulls’ thesis on RGEN. Repligen Corporation's share was trading at $136.44 as of June 30th. RGEN’s trailing and forward P/E were 149.86 and 68.97 respectively according to Yahoo Finance.
[caption id="attachment_519743" align="aligncenter" width="750"]Repligen Corporation, a life sciences company, develops and commercializes bioprocessing technologies and systems in...
Create a free account, or log in to read the full article
No credit card required.
We may use your email to send marketing emails about our services. Click here to read our privacy policy.